Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13)

被引:45
作者
Carapeti, M
Aguiar, RCT
Watmore, AE
Goldman, JM
Cross, NCP
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Haematol, London W12 0NN, England
[2] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA USA
[3] N Trent cytogenet Serv, Ctr Human Genet, Sheffield, S Yorkshire, England
关键词
D O I
10.1016/S0165-4608(99)00007-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have recently cloned the inv(8)(p11q13) in a patient with acute myeloid leukemia (AML), and demonstrated a fusion between the MOZ and TIF2 genes at 8p11 and 8q13, respectively. We have partially characterized a further case of AML with the same karyotypic abnormality. Rearrangements were detected by Southern blotting with a TIF2 probe that rr as close to the breakpoint in the original inv(8) case and with a MOZ probe corresponding to the breakpoint cluster region in the t(8;16) (p11;p13). These findings indicate the existence of breakpoint cluster regions within both genes and demonstrate that the MOZ-TIF2 fusion is consistently associated with the inv(8)(p11q13). (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:70 / 72
页数:3
相关论文
共 9 条
  • [1] Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement
    Aguiar, RCT
    Chase, A
    Coulthard, S
    Macdonald, DHC
    Carapeti, M
    Reiter, A
    Sohal, J
    Lennard, A
    Goldman, JM
    Cross, NCP
    [J]. BLOOD, 1997, 90 (08) : 3130 - 3135
  • [2] The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein
    Borrow, J
    Stanton, VP
    Andresen, JM
    Becher, R
    Behm, FG
    Chaganti, RSK
    Civin, CI
    Disteche, C
    Dube, I
    Frischauf, AM
    Horsman, D
    Mitelman, F
    Volinia, S
    Watmore, AE
    Housman, DE
    [J]. NATURE GENETICS, 1996, 14 (01) : 33 - 41
  • [3] A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia
    Carapeti, M
    Aguiar, RCT
    Goldman, JM
    Cross, NCP
    [J]. BLOOD, 1998, 91 (09) : 3127 - 3133
  • [4] Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant
    Coulthard, S
    Chase, A
    Orchard, K
    Watmore, A
    Vora, A
    Goldman, JM
    Swirsky, DM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (03) : 561 - 563
  • [5] Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)
    Giles, RH
    Dauwerse, JG
    Higgins, C
    Petrij, F
    Wessels, JW
    Beverstock, GC
    Döhner, H
    Jotterand-Bellomo, M
    Falkenburg, JHF
    Slater, RM
    van Ommen, GJB
    Hagemeijer, A
    van der Reijden, BA
    Breuning, MH
    [J]. LEUKEMIA, 1997, 11 (12) : 2087 - 2096
  • [6] Conjunction dysfunction: CBP/p300 in human disease
    Giles, RH
    Peters, DJM
    Breuning, MH
    [J]. TRENDS IN GENETICS, 1998, 14 (05) : 178 - 183
  • [7] Acute mixed lineage, leukemia with an inv(8)(p11g13) resulting in fusion of the genes for MOZ and TIF2
    Liang, J
    Prouty, L
    Williams, BJ
    Dayton, MA
    Blanchard, KL
    [J]. BLOOD, 1998, 92 (06) : 2118 - 2122
  • [8] Steroid receptor coactivator-1 is a histone acetyltransferase
    Spencer, TE
    Jenster, G
    Burcin, MM
    Allis, CD
    Zhou, JX
    Mizzen, CA
    McKenna, NJ
    Onate, SA
    Tsai, SY
    Tsai, MJ
    OMalley, BW
    [J]. NATURE, 1997, 389 (6647) : 194 - 198
  • [9] TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
    Voegel, JJ
    Heine, MJS
    Zechel, C
    Chambon, P
    Gronemeyer, H
    [J]. EMBO JOURNAL, 1996, 15 (14) : 3667 - 3675